Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 8, 2025 / ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

In this week’s Applied Clinical Trials Brief, we recap three top stories: Novo Nordisk’s stepwise approach to AI adoption, ...

About TransCelerate BioPharma Inc. TransCelerate BioPharma (TransCelerate) is a nonprofit organization that fosters collaboration across the global biopharmaceutical research and development community ...

PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract ...

AT278 combines two fundamental properties, ultra-high concentration and an ultra-rapid profile, which provide the potential ...

The diagnostic imaging product 203 Pb-RMX-VH-PIB is an agent that targets the Low-Density Lipoprotein Receptor (LDLR), which ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced a poster ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Invivyd (IVVD) announced that the SPEAR Study Group has issued their consensus recommendation for a clinical study design to evaluate the effects ...